[HTML][HTML] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell …
S Niho, H Kunitoh, H Nokihara, T Horai, Y Ichinose… - Lung cancer, 2012 - Elsevier
PURPOSE: This multicenter, randomized, open-label, phase II study (JO19907) compared
the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
[引用][C] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell …
S NIHO, H KUNITOH, K MATSUI, S NEGORO… - Lung …, 2012 - pascal-francis.inist.fr
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in
Japanese patients with advanced non-squamous non-small-cell lung cancer CNRS Inist …
Japanese patients with advanced non-squamous non-small-cell lung cancer CNRS Inist …
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung …
S Niho, H Kunitoh, H Nokihara, T Horai… - Lung …, 2012 - lungcancerjournal.info
Purpose This multicenter, randomized, open-label, phase II study (JO19907) compared the
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
[PDF][PDF] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell …
S Niho, H Kunitoh, H Nokihara, T Horai, Y Ichinose… - Lung Cancer, 2012 - core.ac.uk
abstract Purpose: This multicenter, randomized, open-label, phase II study (JO19907)
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
[PDF][PDF] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell …
S Niho, H Kunitoh, H Nokihara, T Horai, Y Ichinose… - Lung …, 2012 - academia.edu
abstract Purpose: This multicenter, randomized, open-label, phase II study (JO19907)
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung …
S Niho, H Kunitoh, H Nokihara, T Horai… - Lung Cancer …, 2012 - europepmc.org
Purpose This multicenter, randomized, open-label, phase II study (JO19907) compared the
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung …
S Niho, H Kunitoh, H Nokihara, T Horai… - Lung …, 2012 - okayama.elsevierpure.com
Purpose: This multicenter, randomized, open-label, phase II study (JO19907) compared the
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
[PDF][PDF] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell …
S Niho, H Kunitoh, H Nokihara, T Horai, Y Ichinose… - Lung …, 2012 - researchgate.net
abstract Purpose: This multicenter, randomized, open-label, phase II study (JO19907)
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung …
S Niho, H Kunitoh, H Nokihara… - Lung cancer …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose This multicenter, randomized, open-label, phase II study (JO19907) compared the
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …
[PDF][PDF] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell …
S Niho, H Kunitoh, H Nokihara, T Horai, Y Ichinose… - Lung …, 2012 - cyberleninka.org
abstract Purpose: This multicenter, randomized, open-label, phase II study (JO19907)
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …
compared the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with …